| A1M | alpha-1-microglobulin |
| a2-MG | alpha-2-macroglobulin |
| AMBP | bikunin precursor |
| ACS | acute coronary syndrome |
| AKI | acute kidney injury |
| APP | acute-phase proteins |
| APR | acute-phase response |
| AT-III | antithrombin-3 |
| CKD | chronic kidney disease |
| CPB | carboxypeptidase-B |
| CRC | colorectal cancer |
| DVT | deep vein thrombosis |
| ECM | extracellular matrix |
| EMF | focused electromagnetic field |
| FN | fibrin(ogen) |
| GS | glomerular sclerosis |
| HIF-1 | hypoxia-inducible factor-1 |
| Hp | haptoglobin |
| HSR | heat shock response |
| IalphaI/ITI | inter-alpha-trypsin inhibitor |
| IL | interleukin |
| LMWH | low-molecular-weight heparin |
| LPS | endotoxin/lipopolysaccharide |
| mEHT | modulated electro-hyperthermia |
| MS | mass spectrometry |
| NGS | next-generation sequencing |
| NSCLC | non-small-cell lung cancer |
| PAI | plasminogen activator inhibitor |
| PCR | polymerase chain reaction |
| PE | pulmonary embolism |
| P | properidin |
| PTX3 | pentraxin-related gene |
| RT-PCR | real-time polymerase chain reaction |
| SERPIN | serine protease inhibitor |
| SPA3K | serine protease inhibitor (Serpin)-A3 = alpha-1-anitchymotrypsin |
| SPK | Spa3K inhibitor |
| TAFI | thrombin-activatable fibrinolysis inhibitor |
| TEC | tubular epithelial cell |
| TGF-beta | transforming growth factor beta |
| TME | tumor microenvironment |
| TNBC | triple-negative breast cancer |
| TNF-alpha | tumor necrosis factor-alpha |
| tPA | tissue plasminogen activator |
| TSL | thermo-sensitive liposome |